Showing results (961-970 of 1,197) with videos related to
Sort By:
Pageof 120
International Journal of Environmental Research and Public Health|May 28, 2022
Clinical and Socio-Demographic Variables Associated with the Diagnosis of Long COVID Syndrome in Youth: A Population-Based StudyEugene Merzon, Margaret Weiss, Beth Krone, et al.Pediatric Pulmonology|March 12, 2021
Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiencyKatie A Krone, Abbey J Winant, Sara O Vargas, et al.Journal of Virological Methods|August 1, 1987
Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapyJ Goudsmit, J M Lange, W J Krone, et al.Emerging Infectious Diseases|October 19, 2022
Iceland as Stepping Stone for Spread of Highly Pathogenic Avian Influenza Virus between Europe and North AmericaAnne Günther, Oliver Krone, Vilhjalmur Svansson, et al.Journal of Community Health|August 2, 2020
The Role of Community Health Workers Within the Continuum of Services for HIV, Viral Hepatitis, and Other STIs Amongst Men Who Have Sex with Men in EuropeNicolas Lorente, Nigel Sherriff, Oksana Panochenko, et al.Neuro Endocrinology Letters|December 31, 2024
The use of imagery in group schema therapyJan Prasko, Julius Burkauskas, Julija Gečaitė-Stončienė, et al.Neuro Endocrinology Letters|July 16, 2026
Narrative processes in schema therapy: Theoretical background, clinical methods, and case illustrationsMarie Ociskova, Jan Prasko, Ilona Krone, et al.The Journal of Clinical Endocrinology and Metabolism|September 7, 2006
Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1Felix G Riepe, Johannes Finkeldei, Luisa de Sanctis, et al.European Journal of Endocrinology|February 12, 2017
Steroid hormone analysis in diagnosis and treatment of DSD: position paper of EU COST Action BM 1303 'DSDnet'A Kulle, N Krone, P M Holterhus, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2012
Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cellsAnja Feldmann, Claudia Arndt, Katrin Töpfer, et al.Pageof 120